Agios Pharmaceuticals Inc

NASDAQ:AGIO  
47.17
+1.37 (+2.99%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.86B
Current PEN/A
Forward PE 1.85
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.55 Million
Adjusted EPS-$1.57
See more estimates
10-Day MA$45.84
50-Day MA$47.73
200-Day MA$50.26
See more pivots

Agios Pharmaceuticals Inc Stock, NASDAQ:AGIO

88 Sidney Street, 88 Sidney Street, Cambridge, Massachusetts 02139-4169
United States of America
Phone: +1.617.649.8600
Number of Employees: 562

Description

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.